Loading...
Thumbnail Image
Publication

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.

Schulte-Schrepping, Jonas
Reusch, Nico
Paclik, Daniela
Baßler, Kevin
Schlickeiser, Stephan
Zhang, Bowen
Krämer, Benjamin
Krammer, Tobias
Brumhard, Sophia
Bonaguro, Lorenzo
... show 10 more
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-08-05
Submitted date
Other Titles
Abstract
Coronavirus disease 2019 (COVID-19) is a mild to moderate respiratory tract infection, however, a subset of patients progress to severe disease and respiratory failure. The mechanism of protective immunity in mild forms and the pathogenesis of severe COVID-19 associated with increased neutrophil counts and dysregulated immune responses remain unclear. In a dual-center, two-cohort study, we combined single-cell RNA-sequencing and single-cell proteomics of whole-blood and peripheral-blood mononuclear cells to determine changes in immune cell composition and activation in mild versus severe COVID-19 (242 samples from 109 individuals) over time. HLA-DRhiCD11chi inflammatory monocytes with an interferon-stimulated gene signature were elevated in mild COVID-19. Severe COVID-19 was marked by occurrence of neutrophil precursors, as evidence of emergency myelopoiesis, dysfunctional mature neutrophils, and HLA-DRlo monocytes. Our study provides detailed insights into the systemic immune response to SARS-CoV-2 infection and reveals profound alterations in the myeloid cell compartment associated with severe COVID-19.
Citation
Cell. 2020 Sep 17;182(6):1419-1440.e23. doi: 10.1016/j.cell.2020.08.001.
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Other
Language
en
Description
Series/Report no.
ISSN
EISSN
1097-4172
ISBN
ISMN
Gov't Doc #
Sponsors
License
openAccess
Attribution-NonCommercial-ShareAlike 4.0 International